Alps Advisors Inc

SEC CIK: 0001376113
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overview All 13F holders of ESPR Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of ESPR by Alps Advisors Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−34,653−100.0%	Sold out	Holders
Q3 2021	34,653	$418.0K	<0.1%	−2,480−6.7%	Reduced	Holders
Q2 2021	37,133	$785.0K	<0.1%	−13,296−26.4%	Reduced	Holders
Q1 2021	50,429	$1.42M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.